Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?


EŞKAZAN A. E.

LEUKEMIA, 2020 (SCI İndekslerine Giren Dergi) identifier identifier